LCA decisions in 2025 and through March 31, 2026
Novartis Pharmaceuticals H-1B filings for business intelligence analysts
Short answer
Novartis Pharmaceuticals filed 8 H-1B labor condition applications for business intelligence analysts (LCA decisions in 2025 and through March 31, 2026), 50% of its 16 IT filings. The most common state is New Jersey (8) and the most common city is East Hanover, NJ.
Job titles on the filings
| Job title | Filings |
|---|---|
| Ad, Patient And Provider Analytics - Crm | 1 |
| Associate Director, Patient & Provider Analytics | 1 |
| Associate Director, Psc Operations Insights | 1 |
| Director, Forecasting-Cv | 1 |
| Associate Director, Business Performance - Crm | 1 |
| State | Filings |
|---|---|
| New Jersey | 8 |
| City | Filings |
|---|---|
| East Hanover, NJ | 8 |
Wage levels and offered wage
| Wage level | Filings | Share |
|---|---|---|
| Level III | 1 | 13% |
| Level IV | 7 | 88% |
Median offered wage for business intelligence analysts: $169,541 a year, against a median prevailing wage of $169,541 on the same filings. See prevailing wages by occupation and area.
Other employers filing for business intelligence analysts
| Employer | Filings |
|---|---|
| Uber | 8 |
| Pricewaterhousecoopers Advisory | 8 |
| T-Mobile | 8 |
| Artificial Intelligence Staffing | 8 |
| Artificial Intelligence | 8 |
| Deloitte | 9 |
An LCA is not an approval or a job opening. Corrections: support@matchwire.co.